S'identifier

the second affiliated hospital of nanchang university

2 ARTICLES PUBLISHED IN JoVE

image

Medicine

Application of Straight-needle, Three-tailed, Knot-free, Peritoneal Sutures in Laparoscopic Transabdominal Preperitoneal Hernia Repair
Ning Ma *1, Zhen Zong *2, Fu-xing Tang 1, En-min Huang 1, Tao Ma 1, Wei-sheng Yang 1, Jia-lin Chen 1, Shuang Chen 1, Tai-cheng Zhou 1
1Department of Gastroenterological Surgery and Hernia Center, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, 2Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Nanchang University

Here, we present a protocol to introduce a new peritoneal suture method. This method is called straight-needle, three-tailed, knot-free suture, and we will outline the manufacturing method and clinical application of this suture in detail.

image

Medicine

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Qiang Li *1, Xiaolan Wang *1,2, Deju Li *1, Yulong Liu *3, Kangshou Liu 1, Junjie Liang 1, Jian Sun 1, Quan Jiang 1, Jiexing Li 1, Zhilong Liu 1, Jian Gong 4, Leyang Xiang 1, Zhidong Jia 1, Zhiwei Chen 1, Mingrong Cao 1, Yuchuan Jiang 1,5
1Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, 2Dongpu Branch, The First Affiliated Hospital, Jinan University, 3Department of Vascular Intervention, The First Affiliated Hospital, Jinan University, 4Department of Nuclear Medicine, The First Affiliated Hospital, Jinan University, 5Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University

This study illustrates the methodological potential of combining Yttrium-90 Trans-Arterial Radioembolization (Y-90 TARE) with an anti-PD-1 monoclonal antibody as an effective neoadjuvant strategy leading to hepatectomy in hepatocellular carcinoma (HCC) patients with a high initial recurrence risk. It emphasizes the safety, feasibility, and step-by-step procedural guidance of this approach.

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2024 MyJoVE Corporation. Tous droits réservés.